ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)
$33
About Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Details
Daily high
$10.64
Daily low
$9.31
Price at open
$10.55
52 Week High
$17.96
52 Week Low
$5.50
Market cap
309.0M
Dividend yield
-
Volume
400,500
Avg. volume
677,268
P/E ratio
-3.28
Arcturus Therapeutics Holdings Inc. - Common Stock News
Details
Daily high
$10.64
Daily low
$9.31
Price at open
$10.55
52 Week High
$17.96
52 Week Low
$5.50
Market cap
309.0M
Dividend yield
-
Volume
400,500
Avg. volume
677,268
P/E ratio
-3.28